ADC Therapeutics SA ADCT
1.55 USD +0.02 +1.31%
As of Nov 2, 9:37 AM ET
- YTD
- -56.09%
- 1 year
- -66.52%
- Open
- 1.49
- Prev close
- 1.53
- Mkt cap
- 197.88M
- Vol
- 29.04K
- Avg vol
- 1.56M
- EPS
- -0.60
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.55
- High
- 1.60
- Forward P/E
- -1.36
- Beta
- 1.60
- Short ratio
- 6.98
- Inst. own
- 61.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 2.60
- 200-d avg
- 3.35
- 1y target
- 8.40
MAX chart
Chart tools
Chart is warming up
The all-time price history for ADCT has not been loaded yet. Try again in a moment.
Altman Z-Score
-8.22 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -3.2×
P/S 5.5×
P/B -2.4×
P/FCF -3.2×
EV/EBITDA -7.0×
EV/Sales 7.7×
FCF Yield -31.5%
Gross Margin 90.6%
Operating Margin -133.2%
Net Margin -175.3%
ROE 76.7%
ROIC -42.3%
ROA -44.1%
Revenue 14.9%
Operating Income 17.0%
EPS (diluted) 30.9%
Free Cash Flow -13.4%
Current Ratio 4.4×
Quick Ratio 4.3×
Debt / Equity -2.4×
Net Debt / EBITDA -2.0×
Interest Coverage -2.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31